Rosacea Therapeutics Market to Flourish with an Impressive CAGR by 2024
The American Academy of Dermatology states that over 14 million people are currently living with rosacea in the U.S. alone. The Canadian Dermatology Association reports that this chronic skin condition affects over two million people in the country, while the British Skin Foundation finds that more than eight million people in the U.K. suffer from various skin conditions, including rosacea. The rising incidence of this skin disease has greatly boosted the demand for rosacea therapeutics.
View full press release